BMJ Open. 2021 Jun 21;11(6):e044502. doi: 10.1136/bmjopen-2020-044502.ABSTRACTINTRODUCTION: While the need for palliative care for people living with dementia has widely been recognised, they continue to be a disadvantaged group when it comes to timely initiation, and controversies remain regarding appropriate timing, or what elements constitute high quality palliative care early in the disease trajectory. To date, no literature review has summarised this debate or offered insights. The aim of this scoping review is to provide a general overview of research regarding palliative care in mild or moderate dementia, to identify existing controversies, and to examine what are key components of…
Origen: Earlier initiation of palliative care in the disease trajectory of people living with dementia: a scoping review protocol – PubMed

Gan To Kagaku Ryoho. 2021 Jun;48(6):759-762.ABSTRACTRegarding regional cooperation in palliative care for advanced cancer, the problem is complicated by the fact that the 3 factors of hospital circumstances, regional circumstances, and the patient’s own wishes are different. Depending on the hospital, the patient can be seen to the end, the palliative care resources are different depending on the region, and the patient’s own wishes also change depending on the time. When considering the characteristic trajectory that a cancer patient will follow to the end, it is essential to prepare early, but what is important here is a double primary care…
Origen: Regional Collaboration of Palliative Care to Support the Wishes of Cancer Patients – PubMed

BMC Med Inform Decis Mak. 2021 Jun 15;21(1):189. doi: 10.1186/s12911-021-01555-1.ABSTRACTBACKGROUND: Despite regional efforts to address concerns regarding the burden of advanced cancer in Africa, urgent attention is still required. Widespread issues include late symptom presentation, inaccessibility of palliative care services, limited resources, poor data quality, disparity in data availability, and lack of stakeholder engagement. One way of helping to address these issues is by understanding and meeting the data and information needs of policymakers in palliative cancer care.AIMS: To explore the views of policymakers regarding data availability, data gaps and preferred data formats to support policy and decision making for…
Origen: Data and information needs of policymakers for palliative cancer care: a multi-country qualitative study – PubMed

J Prim Care Community Health. 2021 Jan-Dec;12:21501327211024402. doi: 10.1177/21501327211024402.ABSTRACTOBJECTIVES: This study aimed to understand factors that influence general practitioner (GP) use of automated computer screening to identify patients for the palliative care register (PCR) and the experiences of palliative care and this emerging technology from patients’ and carers’ perspectives.METHODS: A computer screening program electronically searches primary care records in routine clinical practice to identify patients with advanced illness who are not already on a PCR. Five GPs were asked to «think aloud» about adding patients identified by computer screening to the PCR. Key informant interviews with 6 patients on the…
Origen: An Exploratory Qualitative Study of Computer Screening to Support Decision-Making about Use of Palliative Care Registers in Primary Care: GP Think Aloud and Patient and Carer Interviews – PubMed

Br J Radiol. 2021 Jul 1;94(1123):20210012. doi: 10.1259/bjr.20210012. Epub 2021 Jun 16.ABSTRACTOBJECTIVES: To investigate the efficacy of a schedule of low-dose radiotherapy (LDRT) with 4 Gy (2 Gy x 2) in a cohort of unselected MALT or MZL patients.METHODS: We retrospectively collected all patients receiving LDRT, either for cure or palliation, for a stage I-IV histologically proven MALT or MZL between 2016 and 2020. Response to LDRT was evaluated with the Lugano criteria. Local control (LC), distant relapse-free survival (DRFS), progression-free survival (PFS) and overall survival (OS) were stratified for treatment intent (curative vs palliative) and estimated by the Kaplan-Meier…
Origen: Efficacy of low-dose radiotherapy (2 Gy × 2) in the treatment of marginal zone and mucosa-associated lymphoid tissue lymphomas – PubMed